Exagen Inc Ordinary Shares XGN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if XGN is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $1.38
- Day Range
- $1.36–1.41
- 52-Week Range
- $1.30–3.92
- Bid/Ask
- $1.40 / $1.41
- Market Cap
- $24.30 Mil
- Volume/Avg
- 17,178 / 35,236
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.47
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 179
- Website
- https://www.exagen.com
Valuation
|
Metric
|
XGN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.05 |
Price/Sales | 0.47 |
Price/Cash Flow | — |
Price/Earnings
XGN
Financial Strength
|
Metric
|
XGN
|
|---|---|
Quick Ratio | 3.62 |
Current Ratio | 4.02 |
Interest Coverage | −9.78 |
Quick Ratio
XGN
Profitability
|
Metric
|
XGN
|
|---|---|
Return on Assets (Normalized) | −29.76% |
Return on Equity (Normalized) | −64.43% |
Return on Invested Capital (Normalized) | −32.90% |
Return on Assets
XGN
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Hxgkhhrwx | Dlb | $209.3 Bil | |
DHR
| Danaher Corp | Kcsptghhc | Qbwnh | $185.5 Bil | |
IQV
| IQVIA Holdings Inc | Qqgplfz | Fltzbk | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Dlkxxzzjnn | Lwpyjg | $41.0 Bil | |
A
| Agilent Technologies Inc | Zdjnbcszb | Sfbdr | $40.3 Bil | |
MTD
| Mettler-Toledo International Inc | Kqhbwgzm | Mmfxwzf | $26.4 Bil | |
ICLR
| Icon PLC | Ydcqpcts | Xcvrc | $25.2 Bil | |
ILMN
| Illumina Inc | Jzggspts | Cylqqc | $19.6 Bil | |
WAT
| Waters Corp | Nnzncvnsj | Tnmf | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Nzxnrtysg | Gzxnwm | $17.5 Bil |